318 related articles for article (PubMed ID: 36866921)
21. Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.
Warnock L; Gates A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD001401. PubMed ID: 37042825
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF).
Konstan MW; VanDevanter DR; Rowe SM; Wilschanski M; Kerem E; Sermet-Gaudelus I; DiMango E; Melotti P; McIntosh J; De Boeck K;
J Cyst Fibros; 2020 Jul; 19(4):595-601. PubMed ID: 31983658
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.
Frost F; Shaw M; Nazareth D
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013079. PubMed ID: 34889457
[TBL] [Abstract][Full Text] [Related]
24. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW
Cochrane Database Syst Rev; 2013 Nov; (11):CD005599. PubMed ID: 24282073
[TBL] [Abstract][Full Text] [Related]
25. Physical activity and exercise training in cystic fibrosis.
Radtke T; Smith S; Nevitt SJ; Hebestreit H; Kriemler S
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD002768. PubMed ID: 35943025
[TBL] [Abstract][Full Text] [Related]
26. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee TW; Southern KW
Cochrane Database Syst Rev; 2012 Oct; 10():CD005599. PubMed ID: 23076917
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
28. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
Jones M; Moffatt F; Harvey A; Ryan JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
[TBL] [Abstract][Full Text] [Related]
29. Long-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Edwards CT
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012102. PubMed ID: 29253920
[TBL] [Abstract][Full Text] [Related]
30. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
31. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ; Regan KH
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001021. PubMed ID: 29607494
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
[TBL] [Abstract][Full Text] [Related]
33. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
34. Autogenic drainage for airway clearance in cystic fibrosis.
Burnham P; Stanford G; Stewart R
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD009595. PubMed ID: 34910295
[TBL] [Abstract][Full Text] [Related]
35. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD001505. PubMed ID: 31499593
[TBL] [Abstract][Full Text] [Related]
36. Autogenic drainage for airway clearance in cystic fibrosis.
McCormack P; Burnham P; Southern KW
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009595. PubMed ID: 28984368
[TBL] [Abstract][Full Text] [Related]
37. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
McIlwaine M; Button B; Nevitt SJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31774149
[TBL] [Abstract][Full Text] [Related]
38. Inhaled mannitol for cystic fibrosis.
Nevitt SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
[TBL] [Abstract][Full Text] [Related]
39. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
40. Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis.
Smith S; Calthorpe R; Herbert S; Smyth AR
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013733. PubMed ID: 36734528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]